FDA.reportPublic FDA data

Tavneos 10 MG Oral Capsule

RxCUI
2572111
RxNorm name
Tavneos 10 MG Oral Capsule
Display name
Tavneos 10 MG Oral Capsule
Full name
Tavneos 10 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TAVNEOSAVACOPANChemoCentryx, Inc.c93cbc0b-29a3-46a5-9c85-41815ea5cf4a2026-06-02Warnings, Adverse reactionsExact identifier
rxcui: 2572111

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c93cbc0b-29a3-46a5-9c85-41815ea5cf4aTAVNEOS 10 MG Oral Capsule [PSN] · avacopan 10 MG Oral Capsule [Tavneos] [SBD] · Tavneos 10 MG Oral Capsule [SY]313These highlights do not include all the information needed to use TAVNEOS safely and effectively. See full prescribing information for TAVNEOS. TAVNEOS ® (avacopan) capsules, for oral use Initial U.S. Approval: 202120250618